CUSIP: 55068A100
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM CL A
-
Total 13F shares
-
31,093,408
-
Share change
-
+201,778
-
Total reported value
-
$311,351,553
-
Price per share
-
$10.01
-
Number of holders
-
70
-
Value change
-
+$2,347,996
-
Number of buys
-
21
-
Number of sells
-
26
Quarterly Holders Quick Answers
What is CUSIP 55068A100?
CUSIP 55068A100 identifies LUXA - LUX HEALTH TECH ACQUISITION - COM CL A in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP 55068A100:
Institutional Holders of LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) as of Q3 2022
As of 30 Sep 2022,
LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,093,408 shares.
The largest 10 holders included
Empyrean Capital Partners, LP, Sculptor Capital LP, Weiss Asset Management LP, Wolfswood Holdings, LLC, MARSHALL WACE, LLP, Balyasny Asset Management LLC, MIZUHO MARKETS AMERICAS LLC, Saba Capital Management, L.P., BANK OF MONTREAL /CAN/, and GLAZER CAPITAL, LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.